A new article in the peer-reviewed journal Human Gene Therapy describes the consensus reached by invited experts who participated in a meeting to evaluate the potential carcinogenicity of gene therapies.
Appeals court reverses Novartis win over Regeneron in Eylea-Lucentis battle
Regeneron on Monday successfully flipped a lower court’s decision in a hotly-contested case against Novartis regarding the companies’ competing eye injections. The US Court of